Optum has launched a pair of AI-driven prior authorization products, one designed to speed up submissions on the provider side and another to accelerate clinical reviews for payers. The ...

The fetus is an allograft onto the mother and is at risk of rejection, so there is a strong T helper 2 (T H 2)-cell bias to fetal innate immune responses, a tendency also initially manifest in the ...

The association between aging and cancer is well exemplified by bladder cancer: with advancing age, the risk of developing bladder cancer increases, and patients' clinical presentation and outcomes ...